Who Buys Fosfomycin from India — 88 Importers Behind a $12.9M Market

The importation of Fosfomycin from India involves various buyer segments, each with distinct procurement behaviors:

• Distributors: Entities like AVIV Farmaceutica S.A. in Guatemala and MCHZH Konark Pharm in Uzbekistan function as intermediaries, purchasing Fosfomycin in bulk for distribution to healthcare providers. Their procurement is characterized by large-volume orders aimed at optimizing economies of scale.

• Contract Manufacturers: Companies such as CIPLA USA INC UPS SUPPLY CHAIN SOLU and CIPLA USA INC UPS SUPPLY CHAIN SOL in the United States likely import Fosfomycin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules and market demand forecasts.

• Retail Chains: Entities like AMNEAL PHARMACEUTICALS, LLC (KY) and ASCEND LABORATORIES, LLC in the United States may import Fosfomycin to supply their retail pharmacy networks. Their purchasing behavior is influenced by consumer demand and inventory turnover rates.

• Government Procurement: While not explicitly listed among the top buyers, government agencies often procure essential medicines like Fosfomycin through tenders to supply public healthcare facilities. Their procurement is typically large-scale and price-sensitive, focusing on ensuring widespread availability.

• Re-exporters: Some buyers may act as re-exporters, importing Fosfomycin for distribution to neighboring countries, leveraging regional trade agreements and logistical advantages.

Each segment's procurement behavior reflects its role in the pharmaceutical supply chain, with factors such as demand forecasting, regulatory compliance, and market dynamics influencing order patterns.

Import regulations for Fosfomycin vary across the top importing countries:

• United States:
• Regulatory Authority: U.S. Food and Drug Administration (FDA).
• Import Registration Process: Importers must ensure that Fosfomycin is approved by the FDA, with compliance to Current Good Manufacturing Practice (CGMP) regulations.
• Estimated Timeline for Registration: The FDA's drug approval process can range from several months to over a year, depending on the application type and completeness.
• Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the U.S.

• Germany:
• Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
• Import Registration Process: Importers must obtain a marketing authorization from BfArM, demonstrating compliance with the European Medicines Agency (EMA) standards.
• Estimated Timeline for Registration: The process typically takes 7 to 12 months.
• Import Tariff/Duty for HS 30049099: As an EU member, Germany applies a 0% tariff on pharmaceutical products under this HS code.

• Guatemala:
• Regulatory Authority: Ministry of Public Health and Social Assistance (MSPAS).
• Import Registration Process: Importers must register pharmaceutical products with MSPAS, providing documentation on product quality, safety, and efficacy.
• Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months.
• Import Tariff/Duty for HS 30049099: Guatemala imposes a 5% import duty on pharmaceutical products under this HS code.

• Tunisia:
• Regulatory Authority: Pharmacy and Medicines Directorate under the Ministry of Health.
• Import Registration Process: Importers must obtain authorization from the Directorate, ensuring compliance with national pharmaceutical regulations.
• Estimated Timeline for Registration: The process typically takes 6 to 9 months.
• Import Tariff/Duty for HS 30049099: Tunisia applies a 10% import duty on pharmaceutical products under this HS code.

• Uzbekistan:
• Regulatory Authority: Agency for the Development of the Pharmaceutical Industry under the Ministry of Health.
• Import Registration Process: Importers must register pharmaceutical products with the Agency, providing comprehensive documentation on product quality and compliance.
• Estimated Timeline for Registration: The registration process can take 8 to 12 months.
• Import Tariff/Duty for HS 30049099: Uzbekistan imposes a 5% import duty on pharmaceutical products under this HS code.

The demand for Fosfomycin in importing countries is driven by several factors:

• Disease Prevalence: Fosfomycin is primarily used to treat urinary tract infections (UTIs). High incidence rates of UTIs, especially among women and the elderly, contribute to sustained demand.

• Government Healthcare Programs: Many countries have initiatives aimed at improving access to essential medicines. For instance, the inclusion of antibiotics like Fosfomycin in national essential medicines lists facilitates procurement and distribution through public health programs.

• Universal Health Coverage (UHC) Expansion: Efforts to achieve UHC increase access to essential medicines, boosting demand for antibiotics.

• WHO Essential Medicines List Procurement: Fosfomycin's inclusion in the WHO Model List of Essential Medicines encourages its adoption in national formularies, leading to increased procurement by public health systems.

• Tender-Based Purchasing: Government and international health organizations often procure medicines through tenders, ensuring large-scale and cost-effective purchasing. This procurement method supports consistent demand for Fosfomycin.

With 88 buyers across 46 countries, the global market for Fosfomycin reflects its critical role in treating bacterial infections and underscores the importance of strategic procurement and distribution to meet public health needs.

The importation of Fosfomycin from India involves various buyer segments, each with distinct procurement behaviors:

• Distributors: Entities like AVIV Farmaceutica S.A. in Guatemala and MCHZH Konark Pharm in Uzbekistan function as intermediaries, purchasing Fosfomycin in bulk for distribution to healthcare providers. Their procurement is characterized by large-volume orders aimed at optimizing economies of scale.

• Contract Manufacturers: Companies such as CIPLA USA INC UPS SUPPLY CHAIN SOLU and CIPLA USA INC UPS SUPPLY CHAIN SOL in the United States likely import Fosfomycin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules and market demand forecasts.

• Retail Chains: Entities like AMNEAL PHARMACEUTICALS, LLC (KY) and ASCEND LABORATORIES, LLC in the United States may import Fosfomycin to supply their retail pharmacy networks. Their purchasing behavior is influenced by consumer demand and inventory turnover rates.

• Government Procurement: While not explicitly listed among the top buyers, government agencies often procure essential medicines like Fosfomycin through tenders to supply public healthcare facilities. Their procurement is typically large-scale and price-sensitive, focusing on ensuring widespread availability.

• Re-exporters: Some buyers may act as re-exporters, importing Fosfomycin for distribution to neighboring countries, leveraging regional trade agreements and logistical advantages.

Each segment's procurement behavior reflects its role in the pharmaceutical supply chain, with factors such as demand forecasting, regulatory compliance, and market dynamics influencing order patterns.

Import regulations for Fosfomycin vary across the top importing countries:

• United States:
• Regulatory Authority: U.S. Food and Drug Administration (FDA).
• Import Registration Process: Importers must ensure that Fosfomycin is approved by the FDA, with compliance to Current Good Manufacturing Practice (CGMP) regulations.
• Estimated Timeline for Registration: The FDA's drug approval process can range from several months to over a year, depending on the application type and completeness.
• Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the U.S.

• Germany:
• Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
• Import Registration Process: Importers must obtain a marketing authorization from BfArM, demonstrating compliance with the European Medicines Agency (EMA) standards.
• Estimated Timeline for Registration: The process typically takes 7 to 12 months.
• Import Tariff/Duty for HS 30049099: As an EU member, Germany applies a 0% tariff on pharmaceutical products under this HS code.

• Guatemala:
• Regulatory Authority: Ministry of Public Health and Social Assistance (MSPAS).
• Import Registration Process: Importers must register pharmaceutical products with MSPAS, providing documentation on product quality, safety, and efficacy.
• Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months.
• Import Tariff/Duty for HS 30049099: Guatemala imposes a 5% import duty on pharmaceutical products under this HS code.

• Tunisia:
• Regulatory Authority: Pharmacy and Medicines Directorate under the Ministry of Health.
• Import Registration Process: Importers must obtain authorization from the Directorate, ensuring compliance with national pharmaceutical regulations.
• Estimated Timeline for Registration: The process typically takes 6 to 9 months.
• Import Tariff/Duty for HS 30049099: Tunisia applies a 10% import duty on pharmaceutical products under this HS code.

• Uzbekistan:
• Regulatory Authority: Agency for the Development of the Pharmaceutical Industry under the Ministry of Health.
• Import Registration Process: Importers must register pharmaceutical products with the Agency, providing comprehensive documentation on product quality and compliance.
• Estimated Timeline for Registration: The registration process can take 8 to 12 months.
• Import Tariff/Duty for HS 30049099: Uzbekistan imposes a 5% import duty on pharmaceutical products under this HS code.

The demand for Fosfomycin in importing countries is driven by several factors:

• Disease Prevalence: Fosfomycin is primarily used to treat urinary tract infections (UTIs). High incidence rates of UTIs, especially among women and the elderly, contribute to sustained demand.

• Government Healthcare Programs: Many countries have initiatives aimed at improving access to essential medicines. For instance, the inclusion of antibiotics like Fosfomycin in national essential medicines lists facilitates procurement and distribution through public health programs.

• Universal Health Coverage (UHC) Expansion: Efforts to achieve UHC increase access to essential medicines, boosting demand for antibiotics.

• WHO Essential Medicines List Procurement: Fosfomycin's inclusion in the WHO Model List of Essential Medicines encourages its adoption in national formularies, leading to increased procurement by public health systems.

• Tender-Based Purchasing: Government and international health organizations often procure medicines through tenders, ensuring large-scale and cost-effective purchasing. This procurement method supports consistent demand for Fosfomycin.

With 88 buyers across 46 countries, the global market for Fosfomycin reflects its critical role in treating bacterial infections and underscores the importance of strategic procurement and distribution to meet public health needs.